Qualitative and quantitative assessment of endpoints in clinical trials

被引：0
|
作者：
Fridrik, M. A. [1 ]
机构：
[1] Gen Hosp Linz, Ctr Hematol & Med Oncol, Dept Internal Med 3, Linz, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2010年 / 3卷 / 01期
关键词：
Clinical trial; RECIST; endpoints;
D O I：
10.1007/s12254-010-0178-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This review discusses the complexities of different endpoints in clinical trials. A definition of these endpoints and their value for specific situations will be evaluated.
引用
收藏
页码：33 / 36
页数：4
相关论文
共 50 条
  • [31] Choosing endpoints in clinical studies and trials
    B C Chauhan
    Eye, 2007, 21 : S34 - S37
  • [32] OMARKERS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS
    Rosenkranz, Bernd
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S31 - S32
  • [33] Use of composite endpoints in clinical trials
    Sankoh, Abdul J.
    Li, Haihong
    D'Agostino, Ralph B., Sr.
    STATISTICS IN MEDICINE, 2014, 33 (27) : 4709 - 4714
  • [34] Endpoints in trials for clinical liver transplantation
    Washburn, Kenneth
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2008, 13 (03) : 252 - 256
  • [35] Biomarkers and surrogate endpoints in clinical trials
    Fleming, Thomas R.
    Powers, John H.
    STATISTICS IN MEDICINE, 2012, 31 (25) : 2973 - 2984
  • [36] Clinical trials design: protocols and endpoints
    Wyllie, MG
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2000, 12 (Suppl 4) : S53 - S58
  • [37] The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases
    Lonn, E
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) : 497 - 508
  • [38] Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials
    Arbuckle, Rob
    Staunton, Hannah
    Sully, Kate
    Tomkins, Susan
    Khindri, Sanjeev
    Svedsater, Henrik
    Nelsen, Linda
    VALUE IN HEALTH, 2019, 22 (03) : 340 - 347
  • [39] Data capture by digital pen in clinical trials: A qualitative and quantitative study
    Estellat, Candice
    Tubach, Florence
    Costa, Yolande
    Hoffmann, Isabelle
    Mantz, Jean
    Ravaud, Philippe
    CONTEMPORARY CLINICAL TRIALS, 2008, 29 (03) : 314 - 323
  • [40] Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials
    Sherry, Alexander D.
    Lin, Timothy A.
    McCaw, Zachary R.
    Beck, Esther J.
    Kouzy, Ramez
    Abi Jaoude, Joseph
    Passy, Adina H.
    Miller, Avital M.
    Kupferman, Gabrielle S.
    Fuller, Clifton David
    Thomas, Charles R.
    Koay, Eugene J.
    Tang, Chad
    Msaouel, Pavlos
    Ludmir, Ethan B.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (11) : 1939 - 1943
12345